Skip to content

Public FDA record

Z-0107-2027: SEDIPLAST; Model/Catalog Numbers: S-100 and S-1000;

Recall record Z-0107-2027 for POLYMEDCO, INC. / POLYMEDCO CANCER DIAGNOSTIC PRODUCTS, LLC. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0107-2027
Company in FDA record
POLYMEDCO, INC. / POLYMEDCO CANCER DIAGNOSTIC PRODUCTS, LLC
FDA classification date
Oct 7, 2026
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

During use of an affected tube, the operator may encounter increased resistance when inserting the pipette. The resulting pressure buildup may cause the tube cap to detach or be forcibly ejected, potentially resulting in the release of blood and exposure of the operator or surrounding work area to a biological hazard (blood).

Source facts

Action
On August 26, 2026, URGENT PRODUCT RECALL letters were sent to customers. ACTIONS REQUIRED: 1. Examine your inventory and identify all Sediplast Westergren ESR tubes from Lot E1150A. 2. Immediately discontinue use and quarantine all unused tubes from the affected lot. 3. If affected product was distributed to other facilities or locations, immediately forward this notification to those recipients. 4. Contact Polymedco Technical Services to arrange replacement of the affected product and obtain instructions for its return or disposal. 5. Complete and return the enclosed Customer Recall Response Form to Polymedco within five business days, even if you no longer have any affected product in inventory. 6. If affected tubes were previously used without an incident, no additional action is required. If a cap-ejection, blood-spray or exposure incident occurred, follow your facility s applicable biohazard-exposure procedures and report the incident to Polymedco Technical Services. Please do not discard quarantined product until you have received return or disposal instructions from Polymedco.
Initiated
2026-08-25
Root cause
Process control
Distribution
Worldwide - US Nationwide distribution in the states and territory of AK, AR, AZ, CA, CO, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, ND, NH, NJ, NM, NY, OH, OK, OR, PA, PR, SC, SD, TN, TX, UT, VA, WA, WI, WV and the country of United Kingdom.
Recall number
Z-0107-2027
Recall status
Open, Classified
CDRH record ID
222519
FDA classified
2026-10-07
Recall event number
99810

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗